StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)

Close on Nov 17, 2026Market cap $140.36MP/E –Yield –

Drugs Made In America Acquisition II price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Drugs Made In America Acquisition II

Drugs Made In America Acquisition II has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Drugs Made In America Acquisition II figures

See a number that looks wrong?